FXYD5 and adenoma: Next, dysadherin-knockout (Fxyd5-/-) mice were established in a previous study, and we confirmed the role of dysadherin in invasive potential by using a 24-week-old ApcMin/+ mouse model in which tumors ranged from well-differentiated adenomas to invasive adenocarcinomas 10.